2Harnden P,Eardley I,Joyce AD,et al.Cytokeratin 20 as an objective marker of urothelial dysplasea[J].Br J Urol,1996,78(6):870-875.
3Harnden P,Mahmood N,Southgate J. Expression of cytokeratin 20 redefines utothelial papillomas of the bladder[J].Lancet,1999,353(9157):974-977.
4Liukkonen T,Rajala P,Ratlanen M,et al.Prognostic value of MIB-1 score,p53,EGFr,mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer:A prospective comparative study:The Finnbladder Group[J].Eur Urol,1999,36(5):393-400.
5Rodel C,Grabenbauer GG,Rodel F,et al.Apoptosis,p53,bcl-2,and Ki-67 in invasive bladder carcinoma:possible predictors for response to radiochemotherapy and successful bladder preservation[J].Int J Radiat Oncol Biol Phys,2000,46(5):1213-1221.
6Chen G,Lin MS,Li RC.Expression and prognostic value of proliferation cell nuclear antigen in transtional cell carcinoma of the urinary bladder[J].Urol Res,1997,25(1):25-30.
7Hemal AK,Khaitan A,Dinda AK,et al.Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy[J].Urol Int,2003,70(1):42-46.
8Garcia-del-Muro X,Condom E,Vigues F,et al.p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach[J].Cancer,2004,100(9):1859-1867.
9Shariat SF,Tokunaga H,Zhou J,et al.p53,p21,pRB,and p16 expression predict clinical outcome in cystectomy with bladder cancer[J].J Clin Oncol,2004,22(6):1014-1024.
10Chatterjee SJ,Datar R,Youssefzadeh D,et al.Combined effects of p53,p21,and pRb expression in the progression of bladder transitional cell carcinoma[J].J Clin Oncol,2004,22(6):1007-1013.
